MEDA Pharma
- Company typePrivate
- Founded1919
- HeadquartersBad Homburg, Germany
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
MEDA Pharma firmographics
Firmographics- Name
- MEDA Pharma
- Legal name
- MEDA Pharma GmbH & Co.KG
- Website
- https://medapharma.de
- Company type
- Private
- Founded year
- 1919
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
MEDA Pharma industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), Pharmacies and Drug Retailers (456110), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industries
- Generic Hospital & Institutional Products (HLAIABAL), Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC), Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)
Keywords
Where MEDA Pharma is headquartered
LocationHeadquarters
- HQ city
- Bad Homburg
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
MEDA Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- Pharmaceutical Product Sales: Viatris generates revenue through the sale of pharmaceutical products including brand-name medicines, generic drugs, over-the-counter products, vaccines, and biosimilars. The company maintains a diversified portfolio of more than 400 brand products distributed through pharmacy channels.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
MEDA Pharma product offering
Product offeringCore offering
MEDA Pharma manufactures and distributes a diversified portfolio of more than 400 branded pharmaceutical products in Germany, including prescription (Rx) and generic (Gx) medicines, over-the-counter (OTC) products, vaccines, biosimilars, homeopathic remedies, cosmetics, dietary supplements, and medical devices. Production is handled by the subsidiary Madaus GmbH in Troisdorf, and products reach patients via German pharmacies.
Product overview
MEDA Pharma is part of the Viatris Group in Germany and operates as a pharmaceutical company offering a broad portfolio of over 400 branded products. The product portfolio includes Arzneimittel (prescription and generic medicines), Homöopathika (homeopathic products), Kosmetik/Nahrungsergänzungsmittel/Medizinprodukte (cosmetics, dietary supplements, medical devices), as well as Vaccines, Biosimilars, and OTC products. Production is handled through subsidiary Madaus GmbH at the Troisdorf facility. The company is ranked among the Top 15 pharmaceutical providers in Germany, with approximately 1,000 employees in Germany and a global network of around 40 manufacturing sites.
Differentiator
Problem solved
Functional benefit
Products and services
- Arzneimittel (Pharmaceuticals)
Companies that use MEDA Pharma
Customer profileSegments3 records
Ideal customer profiles2 records
MEDA Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MEDA Pharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Madaus GmbHcoreMadaus GmbH is part of the Viatris Group in Germany. It is a mid-sized pharmaceutical company with over 100 years of tradition, operating a production site in Troisdorf with approximately 300 employees. The company handles production, quality management, supply chain, finance, and human resources.
Scale indicators5 records
Recent moves4 records
MEDA Pharma competitors and assessment
Company assessmentBroad incumbents
- Sandoz Group AG: Global generics and biosimilars company spun out of Novartis, with major operations in Germany via Hexal. Direct overlap with MEDA Pharma's generic and biosimilar portfolio and German pharmacy channel.
- Teva Pharmaceutical Industries: Global generics leader with strong presence in Europe including Germany through ratiopharm. Competes with MEDA Pharma across generic and biosimilar categories via similar pharmacy distribution channels.
- Sanofi-Aventis Deutschland GmbH: German subsidiary of global pharma major Sanofi, distributing prescription medicines, vaccines, and consumer health products via German pharmacies. Overlaps with MEDA Pharma's Rx, vaccines, and OTC portfolio.
- Bayer AG (Pharmaceuticals): Global life sciences company headquartered in Germany with a diversified pharmaceutical segment spanning prescription, specialty, and consumer health. Overlaps with MEDA Pharma on Rx and OTC distribution in Germany, but operates at a much larger global scale.
Direct peers
- Dermapharm Holding SE: German pharmaceutical manufacturer specializing in branded generics, OTC, and dermatology products distributed via German pharmacies. Comparable portfolio mix and distribution alignment with MEDA Pharma.
- ratiopharm GmbH: German generic pharmaceutical brand under Teva, distributing prescription and OTC generics across German pharmacies. Closely comparable portfolio and channel overlap with MEDA Pharma's generic and OTC offerings.
- Stada Arzneimittel AG: German-headquartered pharmaceutical company focused on generics, specialty pharma, and consumer healthcare (OTC). Highly comparable to MEDA Pharma given overlapping German footprint, mixed Rx/Gx/OTC portfolio, and pharmacy-led distribution model.
- Klosterfrau Berlin GmbH: German OTC and consumer healthcare company with a portfolio of branded pharmacy products including homeopathic lines. Highly comparable on OTC, homeopathic, and pharmacy-led distribution overlap with MEDA Pharma.
- Hexal AG: One of Germany's largest generic manufacturers and a Sandoz/Novartis subsidiary. Directly competes with MEDA Pharma on generic prescription medicines distributed through German pharmacies with a similar portfolio breadth.
Regional players
- Zentiva Group: European-focused generics manufacturer headquartered in Czechia with significant DACH-region activity. Comparable business model around generics and OTC through European pharmacy distribution.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
MEDA Pharma social profiles
Digital presenceMEDA Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
MEDA Pharma leadership team
Management profileNumber of profiles
MEDA Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MEDA Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MEDA Pharma
What does MEDA Pharma do?
MEDA Pharma manufactures and distributes a diversified portfolio of more than 400 branded pharmaceutical products in Germany, including prescription (Rx) and generic (Gx) medicines, over-the-counter (OTC) products, vaccines, biosimilars, homeopathic remedies, cosmetics, dietary supplements, and medical devices. Production is handled by the subsidiary Madaus GmbH in Troisdorf, and products reach patients via German pharmacies.
Is MEDA Pharma a public or private company?
MEDA Pharma is a private company. It is classified as corporate owned and is currently operating.
When was MEDA Pharma founded?
MEDA Pharma was founded in 1919. It employs 51 to 100 people.
Where is MEDA Pharma based?
MEDA Pharma is headquartered in Bad Homburg, Germany, in the Europe region.
How does MEDA Pharma make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are MEDA Pharma's main competitors?
Broad incumbents on record are Sandoz Group AG, Teva Pharmaceutical Industries, Sanofi-Aventis Deutschland GmbH and Bayer AG (Pharmaceuticals). Direct peers are Dermapharm Holding SE, ratiopharm GmbH, Stada Arzneimittel AG, Klosterfrau Berlin GmbH and Hexal AG. Zentiva Group is listed as a regional player.
Does MEDA Pharma have an API?
No public API is recorded for MEDA Pharma.
What industry is MEDA Pharma in?
MEDA Pharma's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 325412 and its SIC code is 2834.